Resum
The effect of inhaled drugs in community-acquired pneumonia (CAP) is unclear. This case-control study was designed to determine whether inhaled drugs were risk factors for CAP. All incident cases of confirmed CAP that occurred over 1 yr in patients with chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD) or asthma were included, as well as CB, COPD and asthma controls. Risk factors for CAP and inhaled treatment were recorded during a personal interview. An effect of inhaled drugs on the risk of CAP was observed in COPD and asthma patients after adjusting for the effect of other respiratory diseases and their concomitant treatments. In COPD patients, inhaled steroids had a risk OR of 3.26 (95% CI 1.07-9.98) and in asthma patients inhaled anticholinergics had a risk OR of 8.80 (95% CI 1.02-75.7). In CB patients, no association with CAP was observed for any inhaler. These effects were independent of adjusting variables related to severity and other respiratory and non-respiratory risk factors for CAP, including vaccines. Inhaled β2-adrenergic agonists did not show a significant effect on the risk of CAP in any of the respiratory diseases. Inhaled steroids may favour CAP in COPD patients, whereas anticholinergics may favour CAP in asthma patients. It is difficult to differentiate the effect of inhaled therapy from the effect of COPD or asthma severity on the risk of CAP, and these relationships may not be causal, but could call attention to inhaled therapy in COPD and asthma patients. Copyright
Idioma original | Anglès |
---|---|
Pàgines (de-a) | 1080-1087 |
Nombre de pàgines | 8 |
Revista | European Respiratory Journal |
Volum | 36 |
Número | 5 |
DOIs | |
Estat de la publicació | Publicada - 1 de nov. 2010 |
Publicat externament | Sí |
SDG de les Nacions Unides
Aquest resultat contribueix als següents objectius de desenvolupament sostenible.
Accés al document
Altres arxius i enllaços
Fingerprint
Navegar pels temes de recerca de 'Inhaled drugs as risk factors for communityacquired pneumonia'. Junts formen un fingerprint únic.Com citar-ho
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: European Respiratory Journal, Vol. 36, Núm. 5, 01.11.2010, pàg. 1080-1087.
Producció científica: Article en revista indexada › Article › Avaluat per experts
TY - JOUR
T1 - Inhaled drugs as risk factors for communityacquired pneumonia
AU - Almirall, J.
AU - Bolíbar, I.
AU - Serra-Prat, M.
AU - Palomera, E.
AU - Roig, J.
AU - Hospital, I.
AU - Carandelle, E.
AU - Agustí, M.
AU - Ayuso, P.
AU - Estela, A.
AU - Torres, A.
AU - De Salas, J. M.
AU - Costa, J.
AU - Tristany, M.
AU - Grau, M. J.
AU - Sancho, S.
AU - Miguel, E.
AU - Fradera, M.
AU - Ochoa, I.
AU - Castany, M. J.
AU - Quilez, A.
AU - Marina, V.
AU - Subias, P.
AU - Jimeno, B.
AU - Bradnovich,
AU - Rodriguez, M.
AU - Ramon, E.
AU - Gardella, A.
AU - Ginés, C.
AU - Montero, J. C.
AU - Flores, P.
AU - Serra, P.
AU - Torrellas, E.
AU - Serrano, C.
AU - Pubill, M.
AU - Gost, J.
AU - Buxadé, I.
AU - Mussoll, J.
AU - Mestres, X.
AU - Armada, A.
AU - Mallafré, J.
AU - Roger, M.
AU - Gros, M. T.
AU - Les, N.
AU - Joanola, J.
AU - Doménech, J.
AU - Bundó, M.
AU - Trilla, M.
AU - Massons, J.
AU - Montero, J.
AU - Zurilla, E.
AU - Alegre, M.
AU - Papiol, M.
AU - Martí, O.
AU - Catalá, M.
AU - Martinez, M. A.
AU - Casanovas, A.
AU - Beisani, I.
AU - Tria, C.
AU - Diaz, E.
AU - Torán, P.
AU - Aizpurua, M. M.
AU - Lozano, G.
AU - Casals, J.
AU - Sorribes, J.
AU - Torrellas, D.
AU - Casas, A.
AU - Bernad, J.
AU - De Montoliu, A.
AU - Gaya, J.
AU - Vallés, R.
AU - Vazquez, A.
AU - Peiró, R.
AU - Aresté, G.
AU - Mengual, G. N.
AU - Viñes, M. C.
AU - Almerich, E.
AU - Lopez, M. A.
AU - Bel, J.
AU - Gosalves, A.
AU - Macip, S.
AU - Carrillo, E.
AU - Paulo, P.
AU - Pol, M.
AU - Sala, J.
AU - Mir, P.
AU - Anglada, J. L.L.
AU - Salabarnada, J.
AU - Sanz, E.
AU - Gorgas, F.
AU - Ribas, A.
AU - Fau, E.
AU - Pellicer, I.
AU - Morales, S.
AU - Burdoy, E.
AU - Bartolomé, M.
AU - Corona, E.
AU - Mateu, L.
AU - Paret, M.
AU - Verde, Y.
AU - Borrás, A.
AU - Aznar, F.
AU - Riera, F.
AU - Vazquez, A.
AU - Gil, P.
AU - Colom, I.
AU - Calvet, E.
AU - Nicolás, J.
AU - Ruiz, J.
AU - Carrera, P.
AU - Legazpi, I.
AU - Planellas, F.
AU - Beltran, A.
AU - Planas, T.
AU - Rovira, J.
AU - De Ciurana, M.
AU - Xargay, C.
AU - Cortés, R. B.
AU - Paredes, J.
AU - Olive, J. G.
AU - Montoya, P.
AU - El Hosn-Makarem, J. A.
AU - Pelaez, F.
AU - Ubieto, A.
AU - Burcet, F. X.
AU - Alcantarilla, D.
AU - De Ribot, J.
AU - Gorgot, M. R.
AU - Bas, R. A.
AU - Rosa, M. B.
AU - Castells, J.
AU - Castillo, J. A.
AU - Benet, J. M.
AU - Caballero, J. C.
AU - Llach, J.
AU - Sanglas, J.
AU - Moral, V.
AU - Navarro, M.
AU - Torrent, J. C.
AU - Rodríguez, D.
AU - Rius, X.
AU - Solanella, J.
AU - Fallada, A.
AU - Cardona, J. I.
AU - Ferrer, J.
AU - Josa, A.
AU - Solís, M. J.
AU - Güerri, F.
AU - Boj, J.
AU - Ramon, C.
AU - Caballol, R.
AU - Navarro, L.
AU - Masqué, J.
AU - Murillo, M. J.
AU - Llovet, M. D.
AU - Guinea, I.
AU - Juárez, M. M.
AU - Alvarez, M.
AU - Bladé, J.
AU - Sánchez Oró, I.
AU - Martin, F.
AU - Cabré, J. J.
AU - Frigola, J.
AU - Requena, J.
AU - Favà, E.
AU - Pinazo, M. J.
AU - Ros, M.
AU - Borrás, S.
AU - Sala, J.
AU - Nolla, C.
AU - Bitrià, J.
AU - Araujo, O.
AU - Alonso, M.
AU - Glaria, T.
AU - Chacon, A.
AU - Satué, E.
AU - Collado, A.
AU - Llor, Ll
AU - Montanyés, D.
AU - Garcia, G.
AU - Arasa, M. J.
AU - Yoldi, A.
AU - Viloria, I.
AU - Vallespi, F.
AU - Clua, J. L.L.
AU - Basart, J. M.
AU - Ciurana, E.
AU - Monclus, J. F.
AU - Casanovas, A.
AU - Viñas, L.
AU - Checa, E.
AU - Marin, J.
AU - Santigosa, J.
AU - Basora, T.
AU - Gallego, F.
AU - Martin, E.
AU - Gil, P.
AU - Roselló, M.
AU - Arayo, I.
AU - Palacios, F.
AU - Donado, A.
AU - Marimon, J.
AU - Costa, B.
AU - Gutiérrez, C.
AU - Moltó, E.
AU - Isach, A.
AU - Izzeddin, N.
AU - Campani, M.
AU - Ferré, J.
AU - Fernández, A.
AU - Jové, J.
AU - Vilalta, J.
AU - Ribera, E.
AU - Fernández, M.
AU - Ochoa, O.
AU - Vila, A.
AU - Pujol, J.
AU - Navarro, M. A.
AU - Campillos, C.
AU - Juarez, A.
AU - Perez, J.
AU - Casado, I.
AU - Paredes, E.
AU - Rodriguez, J.
AU - Vazquez, A.
AU - Solà, Y.
AU - Berdié, J.
AU - Andrés, M. J.
AU - Barragan, B.
AU - Torras, A.
AU - Madrid, M.
AU - Gonzalez, S.
AU - Fuentes, A.
AU - Iñiguez, M.
AU - Guasch, J.
AU - Sánchez, F.
AU - Pascual, J.
AU - Castelló, A.
AU - Gómez, Ll
AU - Mateu, C.
AU - Arranz, J.
AU - Fé, A.
AU - Puig, B.
AU - Gutiérrez, M.
AU - Morant, Ll
AU - Llull, M.
AU - Estelrich, J.
AU - Quintana, L.
AU - Llabrés, C.
AU - Sureda, M. M.
AU - Cuevas, L.
AU - Muñoz, Y.
AU - Llobera, J.
AU - Marin, P.
AU - Garcia, C.
AU - Moreno, P.
AU - Coll, M.
AU - Palma, C.
AU - Ribera, C.
AU - Aldosa, J.
AU - Alonso, C.
AU - Bergés, A.
AU - Burgués, J.
AU - Burgués, Ll
AU - Busquets, J.
AU - Casal, D.
AU - Cerdán, N.
AU - Crespo, X.
AU - Duat, R.
AU - Escoda, J.
AU - Fiter, M.
AU - Font, A.
AU - Fraysse, M.
AU - Fuentes, S.
AU - García-Núñez, R.
AU - López-Pinacho, T.
AU - Masardo, M.
AU - Martínez-Illescas, J.
AU - Morisset, P.
AU - Pallarés, M.
AU - Pérez-Serra, R.
AU - Plà, A.
AU - Pons, E.
AU - Ruiz, A.
AU - Rodríguez-Picart, J. C.
AU - Sánchez-Claver, J.
AU - Sylvestre, E.
AU - Tolosa, R.
AU - Touceda, J. A.
AU - Varela, J. R.
AU - Vidal, J. C.
AU - Amate, M.
AU - Bara, C.
AU - Becerra, O.
AU - Bellmunt, R.
AU - Boneu, F.
AU - Bozal, J.
AU - Burillo, C.
AU - Díaz, A.
AU - González, N.
AU - Granyena, A.
AU - Gutiérrez, M.
AU - Infante, C.
AU - Leal, M.
AU - Linares, M.
AU - Magallón, J.
AU - Marqués, J.
AU - Martí, M. J.
AU - Miralles, J. C.
AU - Mora, C.
AU - Palacín, J. M.
AU - Pons, J.
AU - Prats, G.
AU - Pujal, G.
AU - Sanjuán, M.
AU - Segarra, X.
AU - Solís, J.
AU - Trelles, H.
AU - De Celis, G.
AU - Latorre, X.
AU - Sarroca, O.
AU - Briceño, H.
PY - 2010/11/1
Y1 - 2010/11/1
N2 - The effect of inhaled drugs in community-acquired pneumonia (CAP) is unclear. This case-control study was designed to determine whether inhaled drugs were risk factors for CAP. All incident cases of confirmed CAP that occurred over 1 yr in patients with chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD) or asthma were included, as well as CB, COPD and asthma controls. Risk factors for CAP and inhaled treatment were recorded during a personal interview. An effect of inhaled drugs on the risk of CAP was observed in COPD and asthma patients after adjusting for the effect of other respiratory diseases and their concomitant treatments. In COPD patients, inhaled steroids had a risk OR of 3.26 (95% CI 1.07-9.98) and in asthma patients inhaled anticholinergics had a risk OR of 8.80 (95% CI 1.02-75.7). In CB patients, no association with CAP was observed for any inhaler. These effects were independent of adjusting variables related to severity and other respiratory and non-respiratory risk factors for CAP, including vaccines. Inhaled β2-adrenergic agonists did not show a significant effect on the risk of CAP in any of the respiratory diseases. Inhaled steroids may favour CAP in COPD patients, whereas anticholinergics may favour CAP in asthma patients. It is difficult to differentiate the effect of inhaled therapy from the effect of COPD or asthma severity on the risk of CAP, and these relationships may not be causal, but could call attention to inhaled therapy in COPD and asthma patients. Copyright
AB - The effect of inhaled drugs in community-acquired pneumonia (CAP) is unclear. This case-control study was designed to determine whether inhaled drugs were risk factors for CAP. All incident cases of confirmed CAP that occurred over 1 yr in patients with chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD) or asthma were included, as well as CB, COPD and asthma controls. Risk factors for CAP and inhaled treatment were recorded during a personal interview. An effect of inhaled drugs on the risk of CAP was observed in COPD and asthma patients after adjusting for the effect of other respiratory diseases and their concomitant treatments. In COPD patients, inhaled steroids had a risk OR of 3.26 (95% CI 1.07-9.98) and in asthma patients inhaled anticholinergics had a risk OR of 8.80 (95% CI 1.02-75.7). In CB patients, no association with CAP was observed for any inhaler. These effects were independent of adjusting variables related to severity and other respiratory and non-respiratory risk factors for CAP, including vaccines. Inhaled β2-adrenergic agonists did not show a significant effect on the risk of CAP in any of the respiratory diseases. Inhaled steroids may favour CAP in COPD patients, whereas anticholinergics may favour CAP in asthma patients. It is difficult to differentiate the effect of inhaled therapy from the effect of COPD or asthma severity on the risk of CAP, and these relationships may not be causal, but could call attention to inhaled therapy in COPD and asthma patients. Copyright
KW - Community-acquired pneumonia
KW - Inhaled drug treatment
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=78349272090&partnerID=8YFLogxK
U2 - 10.1183/09031936.00022909
DO - 10.1183/09031936.00022909
M3 - Article
C2 - 20525710
AN - SCOPUS:78349272090
SN - 0903-1936
VL - 36
SP - 1080
EP - 1087
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 5
ER -